In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways produced impressive improvements in hair regrowth during and after therapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback